Trial ID or NCT#

NCT00349830

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Official Title

Development of Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes

Investigator(s)

Elizabeth Kidd
Elizabeth Kidd
Associate Professor of Radiation Oncology (Radiation Therapy)
Maximilian Diehn, MD, PhD
Maximilian Diehn, MD, PhD
Associate Professor of Radiation Oncology (Radiation Therapy)
Anson Lowe
Anson Lowe
Gastroenterologist, Pancreas specialist, General gastroenterologist
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Billy W Loo, Jr, MD PhD FASTRO
Billy W Loo, Jr, MD PhD FASTRO
Professor of Radiation Oncology (Radiation Therapy)
Quynh-Thu Le, MD
Quynh-Thu Le, MD
Radiation oncologist
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Daniel Chang
Daniel Chang
Sue and Bob McCollum Professor

Contact us to find out if this trial is right for you.

CONTACT

Rene Bonilla
(650) 498-7703